Kessler Hails Leadership, Torti Praises Staff For Brighter Future At FDA
This article was originally published in The Tan Sheet
Executive Summary
Former Commissioner David Kessler sees the appointment of tandem leadership at FDA as a way to re-establish stability and longevity for the agency's senior management
You may also be interested in...
Sharfstein Is Acting FDA Commissioner As Hamburg Awaits Confirmation
Josh Sharfstein will begin his FDA career March 30, serving as acting commissioner while awaiting the confirmation of President Obama's nominee for the spot, Margaret Hamburg
Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA
FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC